This update includes a $125-million charge related to the Thermo-Fisher merger, which negatively affected fourth-quarter 2006 profit.
 
NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said fourth-quarter revenues increased 126 percent as R&D spending rose 36 percent and profit declined by more than half on merger-related charges.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $1.67 billion from $741 million year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.